Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation

In our retrospective series, dose escalation was associated with an improved surgical resection rate in BRPAC and LAPAC patients treated with NACRT, although this improvement was not statistically significant.